AAAAAA
Results: 1-25/568
Authors:
LI QZ
HUDSON W
WANG D
BERVEN E
UCKUN FM
KERSEY JH
Citation: Qz. Li et al., PHARMACOKINETICS AND BIODISTRIBUTION OF RADIOIMMUNOCONJUGATES OF ANTI-CD19 ANTIBODY AND SINGLE-CHAIN FV FOR TREATMENT OF HUMAN B-CELL MALIGNANCY, Cancer immunology and immunotherapy, 47(3), 1998, pp. 121-130
Authors:
SAMANCI A
YI Q
FAGERBERG J
STRIGARD K
SMITH G
RUDEN U
WAHREN B
MELLSTEDT H
Citation: A. Samanci et al., PHARMACOLOGICAL ADMINISTRATION OF GRANULOCYTE MACROPHAGE-CALONY-STIMULATING FACTOR IS OF SIGNIFICANT IMPORTANCE FOR THE INDUCTION OF A STRONG HUMORAL AND CELLULAR-RESPONSE IN PATIENTS IMMUNIZED WITH RECOMBINANT CARCINOEMBRYONIC ANTIGEN/, Cancer immunology and immunotherapy, 47(3), 1998, pp. 131-142
Authors:
SHIMIZU M
TAKEDA Y
YAGITA H
YOSHIMOTO T
MATSUZAWA A
Citation: M. Shimizu et al., ANTITUMOR-ACTIVITY EXHIBITED BY FAS LIGAND (CD95L) OVEREXPRESSED ON LYMPHOID-CELLS AGAINST FAS(-CELLS() TUMOR), Cancer immunology and immunotherapy, 47(3), 1998, pp. 143-148
Authors:
MANTOVANI G
GEBBIA V
AIROLDI M
BUMMA C
CONTU P
BIANCHI A
GHIANI M
DESSI D
MASSA E
CURRELI L
LAMPIS B
LAI P
MULAS C
TESTA A
PROTO E
CADEDDU G
TORE G
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 47(3), 1998, pp. 149-156
Authors:
TONINI G
NUNZIATA C
PRETE SP
PEPPONI R
TURRIZIANI M
MASCI G
GRAZIANI G
BONMASSAR E
DEVECCHIS L
Citation: G. Tonini et al., ADJUVANT TREATMENT OF BREAST-CANCER - A PILOT IMMUNOCHEMOTHERAPY STUDY WITH CMF, INTERLEUKIN-2 AND INTERFERON-ALPHA, Cancer immunology and immunotherapy, 47(3), 1998, pp. 157-166
Authors:
HOFFMANN M
SCHMIDT M
WELS W
Citation: M. Hoffmann et al., ACTIVATION OF EGF RECEPTOR FAMILY MEMBERS SUPPRESSES THE CYTOTOXIC EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA, Cancer immunology and immunotherapy, 47(3), 1998, pp. 167-175
Authors:
ASLAN M
YUCEL G
BOZCUK H
SAVAS B
Citation: M. Aslan et al., THE EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR [RHU GM-CSF) AND RHU G-CSF ADMINISTRATION ON NEUTROPHIL CHEMILUMINESCENCE ASSAY IN PATIENTS FOLLOWING CYCLIC CHEMOTHERAPY/, Cancer immunology and immunotherapy, 47(3), 1998, pp. 176-181
Authors:
CHAPPELL DB
RESTIFO NP
Citation: Db. Chappell et Np. Restifo, T-CELL-TUMOR CELL - A FATAL INTERACTION, Cancer immunology and immunotherapy, 47(2), 1998, pp. 65-71
Authors:
NAGAI E
OGAWA T
KIELIAN T
IKUBO A
SUZUKI T
Citation: E. Nagai et al., IRRADIATED TUMOR-CELLS ADENOVIRALLY ENGINEERED TO SECRETE GRANULOCYTEMACROPHAGE-COLONY-STIMULATING FACTOR ESTABLISH ANTITUMOR IMMUNITY ANDELIMINATE PREEXISTING TUMORS IN SYNGENEIC MICE/, Cancer immunology and immunotherapy, 47(2), 1998, pp. 72-80
Authors:
HUBERT P
GREIMERS R
FRANZENDETROOZ E
DOYEN J
DELANAYE P
BONIVER J
DELVENNE P
Citation: P. Hubert et al., IN-VITRO PROPAGATED DENDRITIC CELLS FROM PATIENTS WITH HUMAN-PAPILLOMA VIRUS-ASSOCIATED PRENEOPLASTIC LESIONS OF THE UTERINE CERVIX - USE OF FLT3 LIGAND, Cancer immunology and immunotherapy, 47(2), 1998, pp. 81-89
Authors:
KIM CH
MATSUMURA M
SAIJO K
OHNO T
Citation: Ch. Kim et al., IN-VITRO INDUCTION OF HLA-A2402-RESTRICTED AND CARCINOEMBRYONIC-ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES ON FIXED AUTOLOGOUS PERIPHERAL-BLOOD CELLS, Cancer immunology and immunotherapy, 47(2), 1998, pp. 90-96
Authors:
YAMAGUCHI T
SUZUKI Y
KATAKURA R
EBINA T
YOKOYAMA J
FUJIMIYA Y
Citation: T. Yamaguchi et al., INTERLEUKIN-15 EFFECTIVELY POTENTIATES THE IN-VITRO TUMOR-SPECIFIC ACTIVITY AND PROLIFERATION OF PERIPHERAL-BLOOD GAMMA-DELTA-T CELLS ISOLATED FROM GLIOBLASTOMA PATIENTS, Cancer immunology and immunotherapy, 47(2), 1998, pp. 97-103
Authors:
METKAR SS
NARESH KN
REDKAR AA
NADKARNI JJ
Citation: Ss. Metkar et al., CD40-LIGATION-MEDIATED PROTECTION FROM APOPTOSIS OF A FAS-SENSITIVE HODGKINS-DISEASE-DERIVED CELL-LINE, Cancer immunology and immunotherapy, 47(2), 1998, pp. 104-112
Authors:
ABRIL E
REAL LM
SERRANO A
JIMENEZ P
GARCIA A
CANTON J
TRIGO I
GARRIDO F
RUIZCABELLO F
Citation: E. Abril et al., UNRESPONSIVENESS TO INTERFERON ASSOCIATED WITH STAT1 PROTEIN-DEFICIENCY IN A GASTRIC ADENOCARCINOMA CELL-LINE, Cancer immunology and immunotherapy, 47(2), 1998, pp. 113-120
Authors:
BASS KK
MASTRANGELO MJ
Citation: Kk. Bass et Mj. Mastrangelo, IMMUNOPOTENTIATION WITH LOW-DOSE CYCLOPHOSPHAMIDE IN THE ACTIVE SPECIFIC IMMUNOTHERAPY OF CANCER, Cancer immunology and immunotherapy, 47(1), 1998, pp. 1-12
Authors:
MA J
SAMUEL J
KWON GS
NOUJAIM AA
MADIYALAKAN R
Citation: J. Ma et al., INDUCTION OF ANTIIDIOTYPIC HUMORAL AND CELLULAR IMMUNE-RESPONSES BY AMURINE MONOCLONAL-ANTIBODY RECOGNIZING THE OVARIAN-CARCINOMA ANTIGEN CA125 ENCAPSULATED IN BIODEGRADABLE MICROSPHERES, Cancer immunology and immunotherapy, 47(1), 1998, pp. 13-20
Authors:
AKAGI J
NAKAGAWA K
EGAMI K
OGAWA M
Citation: J. Akagi et al., INDUCTION OF HLA-UNRESTRICTED AND HLA-CLASS-II-RESTRICTED CYTOTOXIC T-LYMPHOCYTES AGAINST MUC-1 FROM PATIENTS WITH COLORECTAL CARCINOMAS USING RECOMBINANT MUG-I VACCINIA VIRUS, Cancer immunology and immunotherapy, 47(1), 1998, pp. 21-31
Authors:
LI K
ADIBZADEH M
HALDER T
KALBACHER H
HEINZEL S
MULLER C
ZEUTHEN J
PAWELEC G
Citation: K. Li et al., TUMOR-SPECIFIC MHC-CLASS-II-RESTRICTED RESPONSES AFTER IN-VITRO SENSITIZATION TO SYNTHETIC PEPTIDES CORRESPONDING TO GP100 AND ANNEXIN-II ELUTED FROM MELANOMA-CELLS, Cancer immunology and immunotherapy, 47(1), 1998, pp. 32-38
Authors:
PRINSSEN HM
MOLTHOFF CFM
VERHEIJEN RHM
BROADHEAD TJ
KENEMANS P
ROOS JC
DAVIES Q
VANHOF AC
FRIER M
DENHOLLANDER W
WILHELM AJ
BAKER TS
SOPWITH M
SYMONDS EM
PERKINS AC
Citation: Hm. Prinssen et al., BIODISTRIBUTION OF IN-111-LABELED ENGINEERED HUMAN-ANTIBODY CTM01 (HCTM01) IN OVARIAN-CANCER PATIENTS - INFLUENCE OF PRIOR ADMINISTRATION OF UNLABELED HCTM01, Cancer immunology and immunotherapy, 47(1), 1998, pp. 39-46
Authors:
MIYAMOTO M
SHIMIZU Y
OKADA K
KASHII Y
HIGUCHI K
WATANABE A
Citation: M. Miyamoto et al., EFFECT OF INTERLEUKIN-8 ON PRODUCTION OF TUMOR-ASSOCIATED SUBSTANCES AND AUTOCRINE GROWTH OF HUMAN LIVER AND PANCREATIC-CANCER CELLS, Cancer immunology and immunotherapy, 47(1), 1998, pp. 47-57
Authors:
CHAKRABORTY NG
SPORN JR
TORTORA AF
KURTZMAN SH
YAMASE H
ERGIN MT
MUKHERJI B
Citation: Ng. Chakraborty et al., IMMUNIZATION WITH A TUMOR-CELL-LYSATE-LOADED AUTOLOGOUS-ANTIGEN-PRESENTING-CELL-BASED VACCINE IN MELANOMA, Cancer immunology and immunotherapy, 47(1), 1998, pp. 58-64
Authors:
KALINICHENKO TV
MOKYR MB
Citation: Tv. Kalinichenko et Mb. Mokyr, LIMITED IMPORTANCE OF CD40 CD40L INTERACTION IN THE B7-DEPENDENT GENERATION OF ANTI-MOPC-315 CYTOTOXIC T-LYMPHOCYTE ACTIVITY BY TUMOR BEARER SPLENIC CELLS STIMULATED IN-VITRO IN THE PRESENCE OF TUMOR-NECROSIS-FACTOR/, Cancer immunology and immunotherapy, 46(6), 1998, pp. 293-303
Authors:
EISENTHAL A
GOLDMAN Y
SKORNICK Y
GELFAND A
BUYANER D
KAVER I
YELLIN A
YEHOSHUA H
LIFSCHITZMERCER B
GONNENE A
SHINITZKY M
Citation: A. Eisenthal et al., HUMAN TUMOR-CELLS, MODIFIED BY A NOVEL PRESSURE CROSSLINKING METHODOLOGY, PROMOTE AUTOLOGOUS LYMPHOCYTE-PROLIFERATION AND MODULATE CYTOKINESECRETION/, Cancer immunology and immunotherapy, 46(6), 1998, pp. 304-310
Authors:
ORIUCHI N
WATANABE N
KANDA H
HASHIMOTO M
SUGIYAMA S
TAKENOSHITA S
IMAI K
UEDA R
ENDO K
Citation: N. Oriuchi et al., ANTIBODY-DEPENDENT DIFFERENCE IN BIODISTRIBUTION OF MONOCLONAL-ANTIBODIES IN ANIMAL-MODELS AND HUMANS, Cancer immunology and immunotherapy, 46(6), 1998, pp. 311-317
Authors:
MEROPOL NJ
BARRESI GM
FEHNIGER TA
HITT J
FRANKLIN M
CALIGIURI MA
Citation: Nj. Meropol et al., EVALUATION OF NATURAL-KILLER-CELL EXPANSION AND ACTIVATION IN-VIVO WITH DAILY SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS PERIODIC INTERMEDIATE-DOSE PULSING, Cancer immunology and immunotherapy, 46(6), 1998, pp. 318-326